Somerset Healthcare Investment Advisors has made its first investment from its third fund by acquiring Cyrix Healthcare, a medical devices manufacturer based in India, aimed at capitalizing on the growing healthcare market.
Target Information
Cyrix Healthcare is an innovative company specializing in the development of advanced medical devices aimed at enhancing patient care. With a strong focus on technology integration, Cyrix Healthcare has established itself as a significant player in the medical device sector, delivering solutions that improve diagnosis and treatment outcomes across various healthcare settings.
The company prides itself on its R&D capabilities, as well as its commitment to quality and regulatory compliance, ensuring that its products meet the highest standards of safety and efficacy. This approach has enabled Cyrix Healthcare to build a solid reputation and expand its market reach, positioning it well for future growth.
Access Full Deal Insights
You’re viewing a public preview of this deal. To unlock full access to ca. 50,000 other deals in our database and join ca. 400 M&A professionals who are using it daily, sign up for Dealert.
Industry Overview
The medical device industry in India is experiencing robust growth, fueled by increasing healthcare expenditure and a rising demand for advanced medical technologies. India’
Similar Deals
BC Investment (Bain Capital) → Emcure Pharmaceuticals Limited
2025
ADV Partners → Dr. Agarwal’s Healthcare Limited
Kedaara Capital → Vijaya Diagnostic Centre Private Limited
WhiteOak Capital, Creador, Siguler Guff → La Renon Healthcare
Quadria Capital → Maxivision Eye Hospital
Somerset
invested in
Cyrix Healthcare
in 2024
in a Other Private Equity deal